{"transactions":[{"id":728588,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:44:29.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":3127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":3127,"derivative":{"exercise_price":162.99,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":3127},"source":{"system":"sec-edgar","filing":"0001610717-26-000285","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000285/form4.xml","form_type":"4"}},{"id":728587,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-23T21:44:29.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,080 restricted stock units."}],"balance_after":10929,"source":{"system":"sec-edgar","filing":"0001610717-26-000285","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000285/form4.xml","form_type":"4"}},{"id":804264,"issuer":{"id":4435,"kind":"organization","name":"Kailera Therapeutics, Inc.","symbol":"KLRA"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-20T21:04:32.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":38300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable as to 100% of the underlying shares on April 16, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":38300,"derivative":{"exercise_price":16,"expiration_date":"2036-04-16","underlying":"Common Stock","underlying_shares":38300},"source":{"system":"sec-edgar","filing":"0001193125-26-164224","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763963/000119312526164224/ownership.xml","form_type":"4"}},{"id":854068,"issuer":{"id":2994,"kind":"organization","name":"Cencora, Inc.","symbol":"COR"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:21:36.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":557,"price":359.28,"value":200118.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant."}],"balance_after":1724,"source":{"system":"sec-edgar","filing":"0001763963-26-000004","document":"wk-form4_1773087692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1140859/000176396326000004/wk-form4_1773087692.xml","form_type":"4"}},{"id":937586,"issuer":{"id":2994,"kind":"organization","name":"Cencora, Inc.","symbol":"COR"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T21:12:52.000Z","date":"2025-03-11","kind":"other","planned":false,"acquired":true,"shares":4,"price":260.6925,"value":1042.77,"ownership":{"direct":true},"balance_after":1161,"source":{"system":"sec-edgar","filing":"0001763963-26-000002","document":"wk-form5_1768597970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1140859/000176396326000002/wk-form5_1768597970.xml","form_type":"5"}},{"id":1098951,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-30T20:23:55.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":10337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":10337,"derivative":{"exercise_price":37.48,"expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":10337},"source":{"system":"sec-edgar","filing":"0001610717-25-000267","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000267/form4.xml","form_type":"4"}},{"id":1098950,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-30T20:23:55.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":2806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 8,005 Restricted Stock Units."}],"balance_after":9738,"source":{"system":"sec-edgar","filing":"0001610717-25-000267","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000267/form4.xml","form_type":"4"}},{"id":1164755,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-28T22:27:35.000Z","date":"2024-08-05","kind":"grant","planned":false,"acquired":true,"shares":26540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date."}],"balance_after":26540,"derivative":{"exercise_price":42.48,"expiration_date":"2034-08-05","underlying":"Common Stock","underlying_shares":26540},"source":{"system":"sec-edgar","filing":"0001610717-25-000106","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000106/form4.xml","form_type":"4/A","original_submission_date":"2024-08-07"}},{"id":1215582,"issuer":{"id":2994,"kind":"organization","name":"Cencora, Inc.","symbol":"COR"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-10T20:33:09.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":789,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant."}],"balance_after":1157,"source":{"system":"sec-edgar","filing":"0001140859-25-000053","document":"wk-form4_1741638769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1140859/000114085925000053/wk-form4_1741638769.xml","form_type":"4"}},{"id":1375794,"issuer":{"id":2994,"kind":"organization","name":"Cencora, Inc.","symbol":"COR"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:03:49.000Z","date":"2024-11-01","kind":"grant","planned":false,"acquired":true,"shares":368,"price":234.27,"value":86211.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant."}],"balance_after":368,"source":{"system":"sec-edgar","filing":"0001140859-24-000140","document":"wk-form4_1730840623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1140859/000114085924000140/wk-form4_1730840623.xml","form_type":"4"}},{"id":1438435,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-07T21:34:49.000Z","date":"2024-08-05","kind":"grant","planned":false,"acquired":true,"shares":27744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date."}],"balance_after":27744,"derivative":{"exercise_price":42.48,"expiration_date":"2034-08-05","underlying":"Common Stock","underlying_shares":27744},"source":{"system":"sec-edgar","filing":"0001610717-24-000416","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000416/form4.xml","form_type":"4"}},{"id":1438434,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-07T21:34:49.000Z","date":"2024-08-05","kind":"grant","planned":false,"acquired":true,"shares":6932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,932 restricted stock units."}],"balance_after":6932,"source":{"system":"sec-edgar","filing":"0001610717-24-000416","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000416/form4.xml","form_type":"4"}},{"id":1601342,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-06T00:06:13.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":1324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs convert to Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects vesting and settlement of Restricted Stock Units (\"RSUs\") granted on March 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs convert to Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested on March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested on March 1, 2024."}],"balance_after":33682,"derivative":{"underlying":"Common Stock","underlying_shares":1324},"source":{"system":"sec-edgar","filing":"0001225208-24-003735","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520824003735/doc4.xml","form_type":"4"}},{"id":1601341,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-06T00:06:13.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":323,"price":75.88,"value":24509.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects shares withheld for taxes payable upon the vesting of RSUs."}],"balance_after":1847,"source":{"system":"sec-edgar","filing":"0001225208-24-003735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520824003735/doc4.xml","form_type":"4"}},{"id":1601340,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-06T00:06:13.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":1324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects vesting and settlement of Restricted Stock Units (\"RSUs\") granted on March 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs convert to Common Stock on a one-for-one basis."}],"balance_after":2170,"source":{"system":"sec-edgar","filing":"0001225208-24-003735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520824003735/doc4.xml","form_type":"4"}},{"id":1903866,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-05T23:44:55.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":35006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") convert to Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest in three equal tranches with respect to 11,668 shares of Common Stock on each of May 3, 2024, 2025 and 2026, subject to continued employment with IFF."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest in three equal tranches with respect to 11,668 shares of Common Stock on each of May 3, 2024, 2025 and 2026, subject to continued employment with IFF."}],"balance_after":35006,"derivative":{"underlying":"Common Stock","underlying_shares":35006},"source":{"system":"sec-edgar","filing":"0001225208-23-005547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520823005547/doc4.xml","form_type":"4"}},{"id":1982459,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Deferred Stock Units","published_at":"2023-03-02T21:38:43.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":1323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The DSUs convert to Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects vesting and settlement of Deferred Restricted Stock Units (\"DSUs\") granted on March 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The DSUs convert to Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The DSUs vested on March 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The DSUs vested on March 1, 2023."}],"balance_after":5296,"derivative":{"underlying":"Common Stock","underlying_shares":1323},"source":{"system":"sec-edgar","filing":"0001225208-23-003149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520823003149/doc4.xml","form_type":"4"}},{"id":1982458,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:38:43.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":477,"price":91.64,"value":43712.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects shares withheld for taxes payable upon the vesting of DSUs."}],"balance_after":846,"source":{"system":"sec-edgar","filing":"0001225208-23-003149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520823003149/doc4.xml","form_type":"4"}},{"id":1982457,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:38:43.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":1323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects vesting and settlement of Deferred Restricted Stock Units (\"DSUs\") granted on March 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The DSUs convert to Common Stock on a one-for-one basis."}],"balance_after":1323,"source":{"system":"sec-edgar","filing":"0001225208-23-003149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520823003149/doc4.xml","form_type":"4"}},{"id":2280281,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Settled Appreciation Rights","published_at":"2022-05-06T22:32:14.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":53364,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53364,"derivative":{"exercise_price":126.49,"exercise_date":"2025-04-04","expiration_date":"2029-05-04","underlying":"Common Stock","underlying_shares":53364},"source":{"system":"sec-edgar","filing":"0001225208-22-006678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520822006678/doc4.xml","form_type":"4"}},{"id":2280280,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-06T22:32:14.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":10673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") convert to Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs granted under the Equity Choice Program."}],"balance_after":10673,"derivative":{"exercise_date":"2025-04-04","expiration_date":"2025-04-04","underlying":"Common Stock","underlying_shares":10673},"source":{"system":"sec-edgar","filing":"0001225208-22-006678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520822006678/doc4.xml","form_type":"4"}},{"id":2358478,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Settled Appreciation Rights","published_at":"2022-03-04T00:19:17.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":29613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Stock Settled Appreciation Rights will vest in three equal tranches on each of March 1, 2023, March 1, 2024, and March 1, 2025, in each case subject to the reporting person's continued employment with the Company."}],"balance_after":29613,"derivative":{"exercise_price":128.41,"exercise_date":"2023-03-01","expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":29613},"source":{"system":"sec-edgar","filing":"0001225208-22-004197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520822004197/doc4.xml","form_type":"4"}},{"id":2358477,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-04T00:19:17.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":23363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Restricted Stock Units (\"RSUs\") convert to Common Stock on a one-for-one basis."}],"balance_after":23363,"derivative":{"exercise_date":"2025-03-01","expiration_date":"2025-03-01","underlying":"Common Stock","underlying_shares":23363},"source":{"system":"sec-edgar","filing":"0001225208-22-004197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520822004197/doc4.xml","form_type":"4"}},{"id":2358476,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Deferred Stock Units","published_at":"2022-03-04T00:19:17.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":6619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Deferred Restricted Stock Units (\"DSUs\") convert to Common Stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The DSUs will vest in five equal tranches on each of March 1, 2023, March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027, in each case subject to the reporting person's continued employment with the  Company.  The DSUs are payable in Common Stock upon termination of employment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The DSUs will vest in five equal tranches on each of March 1, 2023, March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027, in each case subject to the reporting person's continued employment with the  Company.  The DSUs are payable in Common Stock upon termination of employment."}],"balance_after":6619,"derivative":{"underlying":"Common Stock","underlying_shares":6619},"source":{"system":"sec-edgar","filing":"0001225208-22-004197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520822004197/doc4.xml","form_type":"4"}},{"id":77674,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Restricted Stock Unit","published_at":"2021-11-04T20:21:59.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":39479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in one installment on 5/4/2024."}],"balance_after":39479,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":39479},"source":{"system":"sec-edgar","filing":"0001127602-21-028389","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028389/form4.xml","form_type":"4"}},{"id":78041,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-02T22:16:10.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":19847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option and time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option and time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option became exercisable in equal installments on 5/2/2015, 5/2/2016, and 5/2/2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option and time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."}],"balance_after":19848,"derivative":{"exercise_price":56.49,"exercise_date":"2015-05-02","expiration_date":"2024-05-01","underlying":"Common Stock","underlying_shares":19847},"source":{"system":"sec-edgar","filing":"0001127602-21-028169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/form4.xml","form_type":"4"}},{"id":78040,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-02T22:16:10.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":19915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option and time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option and time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option became exercisable in equal installments on 5/6/2014, 5/6/2015 and 5/6/2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option and time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."}],"balance_after":0,"derivative":{"exercise_price":43.65,"exercise_date":"2014-05-06","expiration_date":"2023-05-05","underlying":"Common Stock","underlying_shares":19915},"source":{"system":"sec-edgar","filing":"0001127602-21-028169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/form4.xml","form_type":"4"}},{"id":78039,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Restricted Stock Unit","published_at":"2021-11-02T22:16:10.000Z","date":"2021-10-30","kind":"exercise","acquired":false,"shares":2358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option and time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vested and were distributed in equal installments on 10/30/2019, 10/30/2020 and 10/30/2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option and time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."}],"balance_after":0,"derivative":{"exercise_date":"2019-10-30","expiration_date":"2021-10-30","underlying":"Common Stock","underlying_shares":2358},"source":{"system":"sec-edgar","filing":"0001127602-21-028169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/form4.xml","form_type":"4"}},{"id":78038,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Common Stock","published_at":"2021-11-02T22:16:10.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":39762,"price":87.8698,"value":3493878.9876,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.8000 to $87.8950, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":97095.087,"source":{"system":"sec-edgar","filing":"0001127602-21-028169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/form4.xml","form_type":"4"}},{"id":78037,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Common Stock","published_at":"2021-11-02T22:16:10.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":19847,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":136857.087,"source":{"system":"sec-edgar","filing":"0001127602-21-028169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/form4.xml","form_type":"4"}},{"id":78036,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Common Stock","published_at":"2021-11-02T22:16:10.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":19915,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":117010.087,"source":{"system":"sec-edgar","filing":"0001127602-21-028169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/form4.xml","form_type":"4"}},{"id":78035,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Common Stock","published_at":"2021-11-02T22:16:10.000Z","date":"2021-10-30","kind":"tax_withholding","acquired":false,"shares":1162,"price":88.05,"value":102314.1,"ownership":{"direct":true},"balance_after":97095.087,"source":{"system":"sec-edgar","filing":"0001127602-21-028169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/form4.xml","form_type":"4"}},{"id":78034,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Common Stock","published_at":"2021-11-02T22:16:10.000Z","date":"2021-10-30","kind":"exercise","acquired":true,"shares":2358,"price":88.05,"value":207621.9,"ownership":{"direct":true},"balance_after":98257.087,"source":{"system":"sec-edgar","filing":"0001127602-21-028169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028169/form4.xml","form_type":"4"}},{"id":88079,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-11T18:41:06.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":19324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in equal installments on 5/6/2014, 5/6/2015 and 5/6/2016."}],"balance_after":19323,"derivative":{"exercise_price":44.98,"exercise_date":"2014-05-06","expiration_date":"2023-05-05","underlying":"Common Stock","underlying_shares":19324},"source":{"system":"sec-edgar","filing":"0001127602-21-016201","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221016201/form4.xml","form_type":"4"}},{"id":88078,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Common Stock","published_at":"2021-05-11T18:41:06.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":19324,"price":78.3192,"value":1513440.2208,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.27 to $78.42, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":94348.057,"source":{"system":"sec-edgar","filing":"0001127602-21-016201","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221016201/form4.xml","form_type":"4"}},{"id":88077,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP & Pres ? Human Health"}}],"security":"Common Stock","published_at":"2021-05-11T18:41:06.000Z","date":"2021-05-10","kind":"exercise","acquired":true,"shares":19324,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":113672.057,"source":{"system":"sec-edgar","filing":"0001127602-21-016201","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221016201/form4.xml","form_type":"4"}},{"id":88509,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-05-06T20:40:08.000Z","date":"2021-05-04","kind":"exercise","acquired":false,"shares":1906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021."}],"balance_after":0,"derivative":{"exercise_date":"2019-05-04","expiration_date":"2021-05-04","underlying":"Common Stock","underlying_shares":1906},"source":{"system":"sec-edgar","filing":"0001127602-21-015744","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015744/form4.xml","form_type":"4"}},{"id":88508,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-06T20:40:08.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":131633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024."}],"balance_after":131633,"derivative":{"exercise_price":75.99,"exercise_date":"2022-05-04","expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":131633},"source":{"system":"sec-edgar","filing":"0001127602-21-015744","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015744/form4.xml","form_type":"4"}},{"id":88507,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-06T20:40:08.000Z","date":"2021-05-04","kind":"tax_withholding","acquired":false,"shares":939,"price":75.98,"value":71345.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":94348.057,"source":{"system":"sec-edgar","filing":"0001127602-21-015744","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015744/form4.xml","form_type":"4"}},{"id":88506,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-05-06T20:40:08.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":1906,"price":75.98,"value":144817.88,"ownership":{"direct":true},"balance_after":95287.057,"source":{"system":"sec-edgar","filing":"0001127602-21-015744","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015744/form4.xml","form_type":"4"}},{"id":2734500,"issuer":{"id":3297,"kind":"organization","name":"DuPont de Nemours, Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-30T20:12:04.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":2207,"price":77.05,"value":170049.35,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes acquisition of shares pursuant to dividend reinvestment."}],"balance_after":8034.4895,"source":{"system":"sec-edgar","filing":"0001666700-21-000027","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666700/000166670021000027/edgar.xml","form_type":"4"}},{"id":92176,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-03-02T16:41:26.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":9432,"price":72.62,"value":684951.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":92588.769,"source":{"system":"sec-edgar","filing":"0001127602-21-008569","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221008569/form4.xml","form_type":"4"}},{"id":99473,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-11-03T21:55:13.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":2287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021."}],"balance_after":2288,"derivative":{"exercise_date":"2019-10-30","expiration_date":"2021-10-30","underlying":"Common Stock","underlying_shares":2287},"source":{"system":"sec-edgar","filing":"0001127602-20-028036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220028036/form4.xml","form_type":"4"}},{"id":99472,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-11-03T21:55:13.000Z","date":"2020-10-30","kind":"tax_withholding","acquired":false,"shares":1137,"price":75.89,"value":86286.93,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":82518.801,"source":{"system":"sec-edgar","filing":"0001127602-20-028036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220028036/form4.xml","form_type":"4"}},{"id":99471,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-11-03T21:55:13.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":2287,"price":75.89,"value":173560.43,"ownership":{"direct":true},"balance_after":83655.801,"source":{"system":"sec-edgar","filing":"0001127602-20-028036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220028036/form4.xml","form_type":"4"}},{"id":102453,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-06T20:53:49.000Z","date":"2020-08-05","kind":"exercise","acquired":false,"shares":18876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015."}],"balance_after":0,"derivative":{"exercise_price":39.29,"exercise_date":"2013-05-02","expiration_date":"2022-05-01","underlying":"Common Stock","underlying_shares":18876},"source":{"system":"sec-edgar","filing":"0001127602-20-023070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220023070/form4.xml","form_type":"4"}},{"id":102452,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-06T20:53:49.000Z","date":"2020-08-05","kind":"sale","acquired":false,"shares":18876,"price":81.5466,"value":1539273.6216,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.5400 to $81.5550, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":80763.106,"source":{"system":"sec-edgar","filing":"0001127602-20-023070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220023070/form4.xml","form_type":"4"}},{"id":102451,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-06T20:53:49.000Z","date":"2020-08-05","kind":"exercise","acquired":true,"shares":18876,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":99639.106,"source":{"system":"sec-edgar","filing":"0001127602-20-023070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220023070/form4.xml","form_type":"4"}},{"id":3130683,"issuer":{"id":3297,"kind":"organization","name":"DuPont de Nemours, Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T20:20:32.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":3438,"price":49.46,"value":170043.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes acquisition of shares pursuant to dividend reinvestment."}],"balance_after":5717.3423,"source":{"system":"sec-edgar","filing":"0001666700-20-000026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666700/000166670020000026/edgar.xml","form_type":"4"}},{"id":104998,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-05-06T21:17:45.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":3752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-05","expiration_date":"2020-05-05","underlying":"Common Stock","underlying_shares":3752},"source":{"system":"sec-edgar","filing":"0001127602-20-015658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220015658/form4.xml","form_type":"4"}},{"id":104997,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-05-06T21:17:45.000Z","date":"2020-05-04","kind":"exercise","acquired":false,"shares":1904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021."}],"balance_after":1906,"derivative":{"exercise_date":"2019-05-04","expiration_date":"2021-05-04","underlying":"Common Stock","underlying_shares":1904},"source":{"system":"sec-edgar","filing":"0001127602-20-015658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220015658/form4.xml","form_type":"4"}},{"id":104996,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-06T21:17:45.000Z","date":"2020-05-05","kind":"tax_withholding","acquired":false,"shares":1848,"price":76.86,"value":142037.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":80763.106,"source":{"system":"sec-edgar","filing":"0001127602-20-015658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220015658/form4.xml","form_type":"4"}},{"id":104995,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-06T21:17:45.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":3752,"price":76.86,"value":288378.72,"ownership":{"direct":true},"balance_after":82611.106,"source":{"system":"sec-edgar","filing":"0001127602-20-015658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220015658/form4.xml","form_type":"4"}},{"id":104994,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-06T21:17:45.000Z","date":"2020-05-04","kind":"tax_withholding","acquired":false,"shares":938,"price":77.67,"value":72854.46,"ownership":{"direct":true},"balance_after":78859.106,"source":{"system":"sec-edgar","filing":"0001127602-20-015658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220015658/form4.xml","form_type":"4"}},{"id":104993,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-05-06T21:17:45.000Z","date":"2020-05-04","kind":"exercise","acquired":true,"shares":1904,"price":77.67,"value":147883.68,"ownership":{"direct":true},"balance_after":79797.106,"source":{"system":"sec-edgar","filing":"0001127602-20-015658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220015658/form4.xml","form_type":"4"}},{"id":105088,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-05T20:37:15.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":75514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023."}],"balance_after":75514,"derivative":{"exercise_price":77.67,"exercise_date":"2021-05-01","expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":75514},"source":{"system":"sec-edgar","filing":"0001127602-20-015441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220015441/form4.xml","form_type":"4"}},{"id":106641,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-03T22:20:28.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":4905,"price":76.56,"value":375526.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":77297.991,"source":{"system":"sec-edgar","filing":"0001127602-20-009129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760220009129/form4.xml","form_type":"4"}},{"id":111220,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-11-01T21:06:16.000Z","date":"2019-10-30","kind":"exercise","acquired":false,"shares":2287,"price":85.1,"value":194623.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021."}],"balance_after":4575,"derivative":{"exercise_date":"2019-10-30","expiration_date":"2021-10-30","underlying":"Common Stock","underlying_shares":2287},"source":{"system":"sec-edgar","filing":"0001225208-19-014014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520819014014/doc4.xml","form_type":"4"}},{"id":111219,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-11-01T21:06:16.000Z","date":"2019-10-30","kind":"tax_withholding","acquired":false,"shares":1127,"price":85.1,"value":95907.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":71904.968,"source":{"system":"sec-edgar","filing":"0001225208-19-014014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520819014014/doc4.xml","form_type":"4"}},{"id":111218,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-11-01T21:06:16.000Z","date":"2019-10-30","kind":"exercise","acquired":true,"shares":2287,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":73031.968,"source":{"system":"sec-edgar","filing":"0001225208-19-014014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520819014014/doc4.xml","form_type":"4"}},{"id":3500627,"issuer":{"id":3297,"kind":"organization","name":"DuPont de Nemours, Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-05T20:33:53.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":2240,"price":76.1,"value":170464.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs."}],"balance_after":2240,"source":{"system":"sec-edgar","filing":"0001666700-19-000049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666700/000166670019000049/edgar.xml","form_type":"4"}},{"id":116820,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-05-13T21:05:24.000Z","date":"2019-05-10","kind":"exercise","acquired":false,"shares":4389,"price":78.33,"value":343790.37,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."}],"balance_after":0,"derivative":{"exercise_date":"2019-05-10","expiration_date":"2019-05-10","underlying":"Common Stock","underlying_shares":4389},"source":{"system":"sec-edgar","filing":"0001104659-19-028974","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919028974/a4.xml","form_type":"4"}},{"id":116819,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-05-13T21:05:24.000Z","date":"2019-05-10","kind":"tax_withholding","acquired":false,"shares":2162,"price":78.33,"value":169349.46,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":69831.087,"source":{"system":"sec-edgar","filing":"0001104659-19-028974","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919028974/a4.xml","form_type":"4"}},{"id":116818,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-05-13T21:05:24.000Z","date":"2019-05-10","kind":"exercise","acquired":true,"shares":4389,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":71993.087,"source":{"system":"sec-edgar","filing":"0001104659-19-028974","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919028974/a4.xml","form_type":"4"}},{"id":116849,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-09T22:11:24.000Z","date":"2019-05-07","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in three equal installments on 5/2/2013, 5/2/2014 and 5/2/2015."}],"balance_after":18876,"derivative":{"exercise_price":39.29,"exercise_date":"2013-05-02","expiration_date":"2022-05-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-19-028305","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919028305/a4.xml","form_type":"4"}},{"id":116848,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-05-09T22:11:24.000Z","date":"2019-05-07","kind":"sale","acquired":false,"shares":25000,"price":77.7273,"value":1943182.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.6400 to $77.8200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":67604.087,"source":{"system":"sec-edgar","filing":"0001104659-19-028305","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919028305/a4.xml","form_type":"4"}},{"id":116847,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-05-09T22:11:24.000Z","date":"2019-05-07","kind":"exercise","acquired":true,"shares":25000,"price":39.29,"value":982250.0,"ownership":{"direct":true},"balance_after":92604.087,"source":{"system":"sec-edgar","filing":"0001104659-19-028305","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919028305/a4.xml","form_type":"4"}},{"id":116941,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-05-07T23:37:58.000Z","date":"2019-05-04","kind":"exercise","acquired":false,"shares":1904,"price":80,"value":152320.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021."}],"balance_after":3810,"derivative":{"exercise_date":"2019-05-04","expiration_date":"2021-05-04","underlying":"Common Stock","underlying_shares":1904},"source":{"system":"sec-edgar","filing":"0001104659-19-027579","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919027579/a4.xml","form_type":"4"}},{"id":116940,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-07T23:37:58.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":50808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022."}],"balance_after":50808,"derivative":{"exercise_price":80,"exercise_date":"2020-05-03","expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":50808},"source":{"system":"sec-edgar","filing":"0001104659-19-027579","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919027579/a4.xml","form_type":"4"}},{"id":116939,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-05-07T23:37:58.000Z","date":"2019-05-04","kind":"tax_withholding","acquired":false,"shares":938,"price":80,"value":75040.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":67604.087,"source":{"system":"sec-edgar","filing":"0001104659-19-027579","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919027579/a4.xml","form_type":"4"}},{"id":116938,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-05-07T23:37:58.000Z","date":"2019-05-04","kind":"exercise","acquired":true,"shares":1904,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68542.087,"source":{"system":"sec-edgar","filing":"0001104659-19-027579","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000110465919027579/a4.xml","form_type":"4"}},{"id":119223,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":11689,"kind":"person","name":"Clyburn Frank","position":1,"cik":"0001763963","reported_name":"Clyburn Frank","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-02-27T23:54:52.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":4017,"price":80.38,"value":322886.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distrubtion of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/16.  Performance shares were paid out at 126 percent of target awards. Includes dividends accured over the three-year performance period ending December 31, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":66188.725,"source":{"system":"sec-edgar","filing":"0001225208-19-003890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000122520819003890/doc4.xml","form_type":"4"}}]}